| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.89 | 0.0001 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |